Excessive Sleepiness

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-11-25
Clinical Trial Update: Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) [Phase 3]
Phase 3 trial update: Axsome Therapeutics is evaluating solriamfetol's modulation of TAAR-1, dopamine, and norepinephrine for shift-work dis…